BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mora JS, Waite C, Gilbert CE, Breidenstein B, Sloper JJ. A worldwide survey of retinopathy of prematurity screening. Br J Ophthalmol 2018;102:9-13. [PMID: 28855196 DOI: 10.1136/bjophthalmol-2017-310709] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Adams GGW. ROP in Asia. Eye (Lond) 2020;34:607-8. [PMID: 31582794 DOI: 10.1038/s41433-019-0620-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Barnett-Itzhaki G, Friehmann A, Barnett-Itzhaki Z, Ela-Dalman N. Diagnosis and Management Practice Patterns among Pediatric Ophthalmology Personnel in Israel. J Binocul Vis Ocul Motil 2019;69:34-41. [PMID: 30896300 DOI: 10.1080/2576117X.2019.1581552] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Le TP, Feng J, Ding L, Hu R, Lou XB, Ulrich JN, Cabrera MT. Survey of current retinopathy of prematurity practices in China. Int J Ophthalmol 2021;14:1241-7. [PMID: 34414091 DOI: 10.18240/ijo.2021.08.17] [Reference Citation Analysis]
4 Li R, Yao G, Zhou L, Zhang M, Yan J, Wang X, Li Y. Autophagy is required for the promoting effect of angiogenic factor with G patch domain and forkhead-associated domain 1 (AGGF1) in retinal angiogenesis. Microvasc Res 2021;138:104230. [PMID: 34339727 DOI: 10.1016/j.mvr.2021.104230] [Reference Citation Analysis]
5 Mutangana F, Muhizi C, Mudereva G, Noë P, Musiime S, Ngambe T, Tuyisenge L, Kumwami M, Nsabimana H, Conard C, Fonteyne Y, Casteels I, De Smedt S; Rwanda Retinopathy of Prematurity Study Group. Retinopathy of prematurity in Rwanda: a prospective multi-centre study following introduction of screening and treatment services. Eye (Lond) 2020;34:847-56. [PMID: 31363176 DOI: 10.1038/s41433-019-0529-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Zhong DJ, Zhang Y, Zhang S, Ge YY, Tong M, Feng Y, You F, Zhao X, Wang K, Zhang L, Liu X, Chen JF. Adenosine A2A receptor antagonism protects against hyperoxia-induced retinal vascular loss via cellular proliferation. FASEB J 2021;35:e21842. [PMID: 34418159 DOI: 10.1096/fj.202100414RR] [Reference Citation Analysis]
7 Kletke SN, Soboka JG, Dimaras H, Sherief ST, Ali A. Development of a pediatric ophthalmology academic partnership between Canada and Ethiopia: a situational analysis. BMC Med Educ 2020;20:438. [PMID: 33198727 DOI: 10.1186/s12909-020-02368-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Pivodic A, Hård AL, Löfqvist C, Smith LEH, Wu C, Bründer MC, Lagrèze WA, Stahl A, Holmström G, Albertsson-Wikland K, Johansson H, Nilsson S, Hellström A. Individual Risk Prediction for Sight-Threatening Retinopathy of Prematurity Using Birth Characteristics. JAMA Ophthalmol 2020;138:21-9. [PMID: 31697330 DOI: 10.1001/jamaophthalmol.2019.4502] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
9 Huang YP, Basanta H, Kang EY, Chen KJ, Hwang YS, Lai CC, Campbell JP, Chiang MF, Chan RVP, Kusaka S, Fukushima Y, Wu WC. Automated detection of early-stage ROP using a deep convolutional neural network. Br J Ophthalmol 2021;105:1099-103. [PMID: 32830123 DOI: 10.1136/bjophthalmol-2020-316526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hellström A, Hård AL. Screening and novel therapies for retinopathy of prematurity - A review. Early Hum Dev 2019;138:104846. [PMID: 31474316 DOI: 10.1016/j.earlhumdev.2019.104846] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
11 Gonski S, Hupp SR, Cotten CM, Clark RH, Laughon M, Watt K, Hornik CP, Kumar K, Smith PB, Greenberg RG. Risk of development of treated retinopathy of prematurity in very low birth weight infants. J Perinatol 2019;39:1562-8. [PMID: 31492920 DOI: 10.1038/s41372-019-0487-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kondo C, Iwahashi C, Utamura S, Kuniyoshi K, Konishi Y, Wada N, Kawasaki R, Kusaka S. Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. Front Pediatr 2022;10:785292. [DOI: 10.3389/fped.2022.785292] [Reference Citation Analysis]
13 Noueihed B, Rivera JC, Dabouz R, Abram P, Omri S, Lahaie I, Chemtob S. Mesenchymal Stromal Cells Promote Retinal Vascular Repair by Modulating Sema3E and IL-17A in a Model of Ischemic Retinopathy. Front Cell Dev Biol 2021;9:630645. [PMID: 33553187 DOI: 10.3389/fcell.2021.630645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kumawat D, Sachan A, Shah P, Chawla R, Chandra P. Aggressive posterior retinopathy of prematurity: a review on current understanding. Eye (Lond) 2021;35:1140-58. [PMID: 33514899 DOI: 10.1038/s41433-021-01392-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Fieß A, Nauen H, Mildenberger E, Zepp F, Urschitz MS, Pfeiffer N, Schuster AK. Ocular geometry in adults born extremely, very and moderately preterm with and without retinopathy of prematurity: results from the Gutenberg Prematurity Eye Study. Br J Ophthalmol 2022:bjophthalmol-2021-320907. [PMID: 35273019 DOI: 10.1136/bjophthalmol-2021-320907] [Reference Citation Analysis]
16 Nikolaidou A, Tsaousis KT. Teleophthalmology and Artificial Intelligence As Game Changers in Ophthalmic Care After the COVID-19 Pandemic. Cureus 2021;13:e16392. [PMID: 34408945 DOI: 10.7759/cureus.16392] [Reference Citation Analysis]
17 Yang Y, Wu Z, Li S, Yang M, Xiao X, Lian C, Wen W, He H, Zeng J, Wang J, Zhang G. Targeted Blood Metabolomic Study on Retinopathy of Prematurity. Invest Ophthalmol Vis Sci 2020;61:12. [PMID: 32049343 DOI: 10.1167/iovs.61.2.12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Pivodic A, Johansson H, Smith LEH, Hård AL, Löfqvist C, Yoder BA, Hartnett ME, Wu C, Bründer MC, Lagrèze WA, Stahl A, Al-Hawasi A, Larsson E, Lundgren P, Gränse L, Sunnqvist B, Tornqvist K, Wallin A, Holmström G, Albertsson-Wikland K, Nilsson S, Hellström A. Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity. Br J Ophthalmol 2021:bjophthalmol-2020-318719. [PMID: 33980506 DOI: 10.1136/bjophthalmol-2020-318719] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lloyd T, Isenberg S, Lambert SR. Current management of retinopathy of prematurity in sub-Saharan Africa. J AAPOS 2020;24:151.e1-6. [PMID: 32505534 DOI: 10.1016/j.jaapos.2020.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Ekhaguere OA, Mairami AB, Kirpalani H. Risk and benefits of Bubble Continuous Positive Airway Pressure for neonatal and childhood respiratory diseases in Low- and Middle-Income countries. Paediatr Respir Rev 2019;29:31-6. [PMID: 29907334 DOI: 10.1016/j.prrv.2018.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
21 Silva JC, Zin A, Gilbert C. Retinopathy of prematurity prevention, screening and treatment programmes: Progress in South America. Semin Perinatol 2019;43:348-51. [PMID: 31182224 DOI: 10.1053/j.semperi.2019.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Swan R, Kim SJ, Campbell JP, Paul Chan RV, Sonmez K, Taylor KD, Li X, Chen YI, Rotter JI, Simmons C, Chiang MF; Imaging and Informatics in ROP Research Consortium. The genetics of retinopathy of prematurity: a model for neovascular retinal disease. Ophthalmol Retina 2018;2:949-62. [PMID: 30250936 DOI: 10.1016/j.oret.2018.01.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
23 Tsai AS, Chou HD, Ling XC, Al-Khaled T, Valikodath N, Cole E, Yap VL, Chiang MF, Chan RVP, Wu WC. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Prog Retin Eye Res 2021;:101018. [PMID: 34763060 DOI: 10.1016/j.preteyeres.2021.101018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Grundy SJ, Tshering L, Wanjala SW, Diamond MB, Audi MS, Prasad S, Shinohara RT, Rogo D, Wangmo D, Wangdi U, Aarayang A, Tshering T, Burke TF, Mateen FJ. Retinal Parameters as Compared with Head Circumference, Height, Weight, and Body Mass Index in Children in Kenya and Bhutan. Am J Trop Med Hyg 2018;99:482-8. [PMID: 29893200 DOI: 10.4269/ajtmh.17-0943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Pivodic A, E.h. Smith L, Hård A, Löfqvist C, Almeida AC, Al-hawasi A, Larsson E, Lundgren P, Sunnqvist B, Tornqvist K, Wallin A, Holmstrom G, Gränse L. Validation of DIGIROP models and decision support tool for prediction of treatment for retinopathy of prematurity on a contemporary Swedish cohort. Br J Ophthalmol. [DOI: 10.1136/bjophthalmol-2021-320738] [Reference Citation Analysis]
26 Pivodic A, Johansson H, Smith LE, Löfqvist C, Albertsson-wikland K, Nilsson S, Hellström A. Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial. BMJ Open Ophth 2022;7:e000923. [DOI: 10.1136/bmjophth-2021-000923] [Reference Citation Analysis]
27 Patel TP, Aaberg MT, Paulus YM, Lieu P, Dedania VS, Qian CX, Besirli CG, Margolis T, Fletcher DA, Kim TN. Smartphone-based fundus photography for screening of plus-disease retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2019;257:2579-85. [PMID: 31501929 DOI: 10.1007/s00417-019-04470-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]